| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 154.72M | 177.04M | 173.58M | 187.38M | 165.84M |
| Gross Profit | 103.15M | 117.26M | 111.11M | 115.13M | 97.69M |
| EBITDA | 99.42M | 108.49M | 121.48M | 131.13M | 121.71M |
| Net Income | 50.83M | 65.62M | 59.14M | 64.09M | 57.21M |
Balance Sheet | |||||
| Total Assets | 953.82M | 908.63M | 832.30M | 813.16M | 748.46M |
| Cash, Cash Equivalents and Short-Term Investments | 405.53M | 395.15M | 306.18M | 289.98M | 231.15M |
| Total Debt | 557.24K | 1.13M | 1.59M | 497.00K | 880.00K |
| Total Liabilities | 131.03M | 179.91M | 186.07M | 187.19M | 192.38M |
| Stockholders Equity | 601.16M | 552.08M | 486.66M | 472.02M | 409.18M |
Cash Flow | |||||
| Free Cash Flow | 34.46M | 71.14M | 84.49M | 85.69M | 109.18M |
| Operating Cash Flow | 47.18M | 76.89M | 89.53M | 100.06M | 129.78M |
| Investing Cash Flow | 15.50M | -159.65M | 16.62M | -60.41M | -25.31M |
| Financing Cash Flow | -16.21M | 9.42M | -60.35M | -17.33M | 4.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$276.00M | 1.79 | 12.01% | ― | -10.28% | -20.25% | |
65 Neutral | HK$3.40B | 6.01 | 10.60% | 5.25% | 1.17% | -0.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$180.18M | 5.02 | 10.40% | 4.64% | 22.78% | ― | |
60 Neutral | HK$3.72B | 4.38 | 6.26% | 6.05% | -66.15% | -21.01% | |
46 Neutral | HK$659.55M | -8.16 | -4.98% | ― | -29.16% | -322.77% | |
40 Underperform | HK$106.44M | -0.32 | 2.58% | ― | 5.76% | -138.78% |